riers compared to values in healthy subjects. Classified by standard hemoglobin electrophoresis, there were 46 healthy subjects and 11 hemoglobin E carriers. There are no significant differences in platelet count and platelet parameters between the two groups (p > 0.05). Although there are reports that indicate the change in the quality of platelet in hemoglobin E disorders, no quantitative disorder was detected. There was no trend toward increased platelet count in the HbE carriers.
Hemoglobinopathies are an important inherited disorder with a high prevalence in Thailand. Of several hemoglobinopathies, hemoglobin E (HbE) disorder (beta 26, GAG-AAG, Glu-Lys) is the most common form. Heterozygotes and homozygotes for HbE are microcytic, minimally anemic, and asymptomatic. The microcytosis is attributed to the beta thalassemic nature of the beta E gene, whereas the in vitro instability of HbE does not contribute to the phenotype (1) .
Coagulation disorders in these patients have also been proposed. Even though thrombotic risks in the patients with hemoglobin disorders from standpoints of platelet dysfunction and coagulation factors are controversial, they are in favor of thrombosis due to thrombocytosis (2) . Therefore, a study focusing on the thrombopathology in the patients with hemoglobin dis-order is of interest. We performed a study to evaluate the platelet count and platelet parameters in HbE carriers comparing to values in healthy subjects.
MATERIALS AND METHODS
We performed this descriptive study using 57 healthy Thai young adults. All have no overt hematologic disorders. A venous blood specimen from each subject was collected in EDTA tubes and analyzed according to the following categories. Standard hemoglobin electrophoresis was performed. Each blood sample was also tested for platelet count and platelet parameters using an automated hematology analyzer, Technicon H*3.
All laboratory data were collected and used for further analysis. The comparison between groups was performed using an unpaired t test. The statistically significant level was set at p value ≤ 0.05. All statistical analysis was performed using SPSS11 for Windows program. 
RESULTS
Classified by standard hemoglobin electrophoresis, there were two groups of subjects. The first group, 46 subjects, was the group of healthy subjects (genotype A2A) and the second group, 11 subjects, was the group of subjects who carried hemoglobin E (genotype EA).
The platelet count and platelet parameters of the two groups are presented in Table 1 . There is no significant difference of platelet count and platelet parameters between two groups (p > 0.05).
DISCUSSION
Hemostatic disorder is mentioned as a hematologic finding in hemoglobinopathies disorders. Previous studies suggested that the important hemostatic changes in patients with hemoglobinopathies are a) decreased natural anticoagulants and b) enhanced procoagulant. Other alterations are the decreased von Willebrand factor and thrombocytosis (3) .
Study of platelet reversibility from pseudopods to smooth surface showed that hemoglobin disorder platelets had poorer reversibility than normal platelets (4). The shape changes and impaired reversibility of platelet pseudopods may be associated with the high tendency of pulmonary thrombus in patients who carry HbE (4) .
Although there are reports that indicate the change in the quality of platelet in hemoglobin E disorders (2), we detect no quantitative disorder in our observation. Also, we detect no trend of increased platelet count in the HbE carriers. The null effect of hemoglobin E on the platelet amount can be confirmed (5) . However, because the total number of subjects in our study is limited, further study is necessary. 
